{
  "DOI": "10.1007/s10689-010-9365-2",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-010-9365-2",
  "alternative-id": [
    "9365"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Almendingen",
      "given": "Kari",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Larsen",
      "given": "Laila N.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fausa",
      "given": "Olav",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bratlie",
      "given": "Jorunn",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Høstmark",
      "given": "Arne T.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Aabakken",
      "given": "Lars",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2010,
        6,
        30
      ]
    ],
    "date-time": "2010-06-30T11:36:45Z",
    "timestamp": 1277897805000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        10,
        30
      ]
    ],
    "date-time": "2021-10-30T11:09:30Z",
    "timestamp": 1635592170000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        13
      ]
    ],
    "date-time": "2023-09-13T19:33:09Z",
    "timestamp": 1694633589180
  },
  "is-referenced-by-count": 6,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2010,
        7,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2010,
          12
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://www.springerlink.com/index/pdf/10.1007/s10689-010-9365-2",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "571-580",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2010,
        7,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2010,
        7,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(08)61490-7",
      "author": "JA Baron",
      "doi-asserted-by": "crossref",
      "first-page": "1756",
      "journal-title": "Lancet",
      "key": "9365_CR1",
      "unstructured": "Baron JA, Sandler RS, Bresalier RS, Lanas A, Morton DG, Riddell R, Iverson ER, Demets DL (2008) Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet 372:1756–1764",
      "volume": "372",
      "year": "2008"
    },
    {
      "DOI": "10.1124/mol.109.057844",
      "author": "LI Brueggemann",
      "doi-asserted-by": "crossref",
      "first-page": "1053",
      "issue": "5",
      "journal-title": "Mol Pharmacol",
      "key": "9365_CR2",
      "unstructured": "Brueggemann LI, Mackie AR, Mani BK, Cribbs LL, Byron KL (2009) Differential effects of selective COX-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles. Mol Pharmacol 76(5):1053–1061",
      "volume": "76",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1940-6207.CAPR-09-0033",
      "author": "LJ Marnett",
      "doi-asserted-by": "crossref",
      "first-page": "288",
      "journal-title": "Cancer Prev Res (Phila Pa)",
      "key": "9365_CR3",
      "unstructured": "Marnett LJ (2009) Mechanisms of cyclooxygenase-2 inhibition and cardiovascular side effects: the plot thickens. Cancer Prev Res (Phila Pa) 2:288–290",
      "volume": "2",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.296.13.jrv60011",
      "author": "P McGettigan",
      "doi-asserted-by": "crossref",
      "first-page": "1633",
      "journal-title": "JAMA",
      "key": "9365_CR4",
      "unstructured": "McGettigan P, Henry D (2006) Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296:1633–1644",
      "volume": "296",
      "year": "2006"
    },
    {
      "DOI": "10.1001/archinte.165.5.ioi50013",
      "author": "TJ Aw",
      "doi-asserted-by": "crossref",
      "first-page": "490",
      "journal-title": "Arch Intern Med",
      "key": "9365_CR5",
      "unstructured": "Aw TJ, Haas SJ, Liew D, Krum H (2005) Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. Arch Intern Med 165:490–496",
      "volume": "165",
      "year": "2005"
    },
    {
      "DOI": "10.1097/00045391-200309000-00002",
      "author": "J Cho",
      "doi-asserted-by": "crossref",
      "first-page": "311",
      "journal-title": "Am J Ther",
      "key": "9365_CR6",
      "unstructured": "Cho J, Cooke CE, Proveaux W (2003) A retrospective review of the effect of COX-2 inhibitors on blood pressure change. Am J Ther 10:311–317",
      "volume": "10",
      "year": "2003"
    },
    {
      "key": "9365_CR7",
      "unstructured": "World Health Organization (2003) Diet, nutrition, and the prevention of chronic diseases. World Health Organization, Geneva"
    },
    {
      "DOI": "10.1007/s12082-007-0105-4",
      "doi-asserted-by": "crossref",
      "key": "9365_CR8",
      "unstructured": "World Cancer Research Fund (2007) Food, nutrition and the prevention of cancer: a global perspective Washington, DC, American Institute for Cancer Research, 1"
    },
    {
      "DOI": "10.1093/carcin/bgp014",
      "author": "A Greenhough",
      "doi-asserted-by": "crossref",
      "first-page": "377",
      "journal-title": "Carcinogenesis",
      "key": "9365_CR9",
      "unstructured": "Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A (2009) The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30:377–386",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.3748/wjg.v9.i9.1990",
      "author": "AW Wu",
      "doi-asserted-by": "crossref",
      "first-page": "1990",
      "journal-title": "World J Gastroenterol",
      "key": "9365_CR10",
      "unstructured": "Wu AW, Gu J, Ji JF, Li ZF, Xu GW (2003) Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients’ prognosis. World J Gastroenterol 9:1990–1994",
      "volume": "9",
      "year": "2003"
    },
    {
      "DOI": "10.1073/pnas.0334211100",
      "author": "D Bagga",
      "doi-asserted-by": "crossref",
      "first-page": "1751",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "9365_CR11",
      "unstructured": "Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST (2003) Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 100:1751–1756",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1126/science.1651562",
      "author": "KW Kinzler",
      "doi-asserted-by": "crossref",
      "first-page": "661",
      "journal-title": "Science",
      "key": "9365_CR12",
      "unstructured": "Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661–665",
      "volume": "253",
      "year": "1991"
    },
    {
      "DOI": "10.1136/gut.2007.136127",
      "author": "HF Vasen",
      "doi-asserted-by": "crossref",
      "first-page": "704",
      "journal-title": "Gut",
      "key": "9365_CR13",
      "unstructured": "Vasen HF, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Jarvinen H, Mecklin JP, Moller P, Myrhoi T, Nagengast FM, Parc Y, Phillips R, Clark SK, de Leon MP, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704–713",
      "volume": "57",
      "year": "2008"
    },
    {
      "DOI": "10.1136/gut.2003.027771",
      "author": "S Bulow",
      "doi-asserted-by": "crossref",
      "first-page": "381",
      "journal-title": "Gut",
      "key": "9365_CR14",
      "unstructured": "Bulow S, Bjork J, Christensen IJ, Fausa O, Jarvinen H, Moesgaard F, Vasen HF (2004) Duodenal adenomatosis in familial adenomatous polyposis. Gut 53:381–386",
      "volume": "53",
      "year": "2004"
    },
    {
      "author": "M Oshima",
      "first-page": "1733",
      "journal-title": "Cancer Res",
      "key": "9365_CR15",
      "unstructured": "Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E, Taketo MM, Evans JF (2001) Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 61:1733–1740",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1007/s10147-005-0548-z",
      "author": "T Iwama",
      "doi-asserted-by": "crossref",
      "first-page": "133",
      "journal-title": "Int J Clin Oncol",
      "key": "9365_CR16",
      "unstructured": "Iwama T, Akasu T, Utsunomiya J, Muto T (2006) Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial. Int J Clin Oncol 11:133–139",
      "volume": "11",
      "year": "2006"
    },
    {
      "DOI": "10.1136/gut.50.6.857",
      "author": "RK Phillips",
      "doi-asserted-by": "crossref",
      "first-page": "857",
      "journal-title": "Gut",
      "key": "9365_CR17",
      "unstructured": "Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP, Wakabayashi N, Shen Y, Zimmerman S, Godio L, Rodrigues-Bigas M, Su LK, Sherman J, Kelloff G, Levin B, Steinbach G (2002) A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 50:857–860",
      "volume": "50",
      "year": "2002"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-2379",
      "author": "LA Brosens",
      "doi-asserted-by": "crossref",
      "first-page": "4090",
      "journal-title": "Clin Cancer Res",
      "key": "9365_CR18",
      "unstructured": "Brosens LA, Iacobuzio-Donahue CA, Keller JJ, Hustinx SR, Carvalho R, Morsink FH, Hylind LM, Offerhaus GJ, Giardiello FM, Goggins M (2005) Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the −765G→C COX-2 polymorphism. Clin Cancer Res 11:4090–4096",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.bcp.2008.04.017",
      "author": "S Schiffmann",
      "doi-asserted-by": "crossref",
      "first-page": "179",
      "journal-title": "Biochem Pharmacol",
      "key": "9365_CR19",
      "unstructured": "Schiffmann S, Maier TJ, Wobst I, Janssen A, Corban-Wilhelm H, Angioni C, Geisslinger G, Grosch S (2008) The anti-proliferative potency of celecoxib is not a class effect of coxibs. Biochem Pharmacol 76:179–187",
      "volume": "76",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-2379",
      "author": "LA Brosens",
      "doi-asserted-by": "crossref",
      "first-page": "4090",
      "journal-title": "Clin Cancer Res",
      "key": "9365_CR20",
      "unstructured": "Brosens LA, Iacobuzio-Donahue CA, Keller JJ, Hustinx SR, Carvalho R, Morsink FH, Hylind LM, Offerhaus GJ, Giardiello FM, Goggins M (2005) Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the −765G→C COX-2 polymorphism. Clin Cancer Res 11:4090–4096",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s12082-007-0105-4",
      "doi-asserted-by": "crossref",
      "key": "9365_CR21",
      "unstructured": "World Cancer Research Fund (2007) Food, nutrition and the prevention of cancer: a global perspective Washington, DC, American Institute for Cancer Research, 1"
    },
    {
      "DOI": "10.1002/ijc.22337",
      "author": "K Almendingen",
      "doi-asserted-by": "crossref",
      "first-page": "632",
      "journal-title": "Int J Cancer",
      "key": "9365_CR22",
      "unstructured": "Almendingen K, Hostmark AT, Fausa O, Mosdol A, Aabakken L, Vatn MH (2007) Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids. Int J Cancer 120:632–637",
      "volume": "120",
      "year": "2007"
    },
    {
      "DOI": "10.1038/bjc.1991.73",
      "author": "S McClinton",
      "doi-asserted-by": "crossref",
      "first-page": "314",
      "journal-title": "Br J Cancer",
      "key": "9365_CR23",
      "unstructured": "McClinton S, Moffat LE, Horrobin DF, Manku MS (1991) Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer 63:314–316",
      "volume": "63",
      "year": "1991"
    },
    {
      "DOI": "10.1177/0148607189013005501",
      "author": "C Mosconi",
      "doi-asserted-by": "crossref",
      "first-page": "501",
      "journal-title": "JPEN J Parenter Enteral Nutr",
      "key": "9365_CR24",
      "unstructured": "Mosconi C, Agradi E, Gambetta A, Bozzetti F, Galli C (1989) Decrease of polyunsaturated fatty acids and elevation of the oleic/stearic acid ratio in plasma and red blood cell lipids of malnourished cancer patients. JPEN J Parenter Enteral Nutr 13:501–504",
      "volume": "13",
      "year": "1989"
    },
    {
      "DOI": "10.1016/S0306-9877(97)90024-4",
      "author": "AR Eynard",
      "doi-asserted-by": "crossref",
      "first-page": "55",
      "journal-title": "Med Hypotheses",
      "key": "9365_CR25",
      "unstructured": "Eynard AR (1997) Does chronic essential fatty acid deficiency constitute a pro-tumorigenic condition? Med Hypotheses 48:55–62",
      "volume": "48",
      "year": "1997"
    },
    {
      "DOI": "10.1016/S0026-0495(96)90194-8",
      "author": "EN Siguel",
      "doi-asserted-by": "crossref",
      "first-page": "12",
      "journal-title": "Metabolism",
      "key": "9365_CR26",
      "unstructured": "Siguel EN, Lerman RH (1996) Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 45:12–23",
      "volume": "45",
      "year": "1996"
    },
    {
      "DOI": "10.1016/S0022-2275(20)37146-7",
      "author": "DM Minich",
      "doi-asserted-by": "crossref",
      "first-page": "1709",
      "journal-title": "J Lipid Res",
      "key": "9365_CR27",
      "unstructured": "Minich DM, Vonk RJ, Verkade HJ (1997) Intestinal absorption of essential fatty acids under physiological and essential fatty acid-deficient conditions. J Lipid Res 38:1709–1721",
      "volume": "38",
      "year": "1997"
    },
    {
      "DOI": "10.1016/S0026-0495(96)90194-8",
      "author": "EN Siguel",
      "doi-asserted-by": "crossref",
      "first-page": "12",
      "journal-title": "Metabolism",
      "key": "9365_CR28",
      "unstructured": "Siguel EN, Lerman RH (1996) Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 45:12–23",
      "volume": "45",
      "year": "1996"
    },
    {
      "DOI": "10.1136/gut.2007.136127",
      "author": "HF Vasen",
      "doi-asserted-by": "crossref",
      "first-page": "704",
      "journal-title": "Gut",
      "key": "9365_CR29",
      "unstructured": "Vasen HF, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Jarvinen H, Mecklin JP, Moller P, Myrhoi T, Nagengast FM, Parc Y, Phillips R, Clark SK, de Leon MP, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704–713",
      "volume": "57",
      "year": "2008"
    },
    {
      "author": "K Almendingen",
      "key": "9365_CR30",
      "unstructured": "Almendingen K, Fausa O, Hostmark AT, Bratlie J (2009) Morkerid L. Aabakken L, Vatn MH. Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway. Eur J Nutr",
      "volume-title": "Morkerid L",
      "year": "2009"
    },
    {
      "DOI": "10.1002/ijc.22337",
      "author": "K Almendingen",
      "doi-asserted-by": "crossref",
      "first-page": "632",
      "journal-title": "Int J Cancer",
      "key": "9365_CR31",
      "unstructured": "Almendingen K, Hostmark AT, Fausa O, Mosdol A, Aabakken L, Vatn MH (2007) Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids. Int J Cancer 120:632–637",
      "volume": "120",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0140-6736(08)61490-7",
      "author": "JA Baron",
      "doi-asserted-by": "crossref",
      "first-page": "1756",
      "journal-title": "Lancet",
      "key": "9365_CR32",
      "unstructured": "Baron JA, Sandler RS, Bresalier RS, Lanas A, Morton DG, Riddell R, Iverson ER, Demets DL (2008) Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet 372:1756–1764",
      "volume": "372",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s00394-008-0772-1",
      "doi-asserted-by": "crossref",
      "key": "9365_CR33",
      "unstructured": "Almendingen K, Fausa O, Hostmark AT, Bratlie J, Morkerid L, Aabakken L, Vatn MH (2009) Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway. Eur J Nutr"
    },
    {
      "DOI": "10.1002/ijc.22337",
      "author": "K Almendingen",
      "doi-asserted-by": "crossref",
      "first-page": "632",
      "journal-title": "Int J Cancer",
      "key": "9365_CR34",
      "unstructured": "Almendingen K, Hostmark AT, Fausa O, Mosdol A, Aabakken L, Vatn MH (2007) Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids. Int J Cancer 120:632–637",
      "volume": "120",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0026-0495(96)90194-8",
      "author": "EN Siguel",
      "doi-asserted-by": "crossref",
      "first-page": "12",
      "journal-title": "Metabolism",
      "key": "9365_CR35",
      "unstructured": "Siguel EN, Lerman RH (1996) Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 45:12–23",
      "volume": "45",
      "year": "1996"
    },
    {
      "DOI": "10.1016/S0022-2275(20)37146-7",
      "author": "DM Minich",
      "doi-asserted-by": "crossref",
      "first-page": "1709",
      "journal-title": "J Lipid Res",
      "key": "9365_CR36",
      "unstructured": "Minich DM, Vonk RJ, Verkade HJ (1997) Intestinal absorption of essential fatty acids under physiological and essential fatty acid-deficient conditions. J Lipid Res 38:1709–1721",
      "volume": "38",
      "year": "1997"
    },
    {
      "DOI": "10.1007/s12082-007-0105-4",
      "doi-asserted-by": "crossref",
      "key": "9365_CR37",
      "unstructured": "World Cancer Research Fund (2007) Food, nutrition and the prevention of cancer: a global perspective Washington, DC, American Institute for Cancer Research, 1"
    },
    {
      "DOI": "10.1177/0148607189013005501",
      "author": "C Mosconi",
      "doi-asserted-by": "crossref",
      "first-page": "501",
      "journal-title": "JPEN J Parenter Enteral Nutr",
      "key": "9365_CR38",
      "unstructured": "Mosconi C, Agradi E, Gambetta A, Bozzetti F, Galli C (1989) Decrease of polyunsaturated fatty acids and elevation of the oleic/stearic acid ratio in plasma and red blood cell lipids of malnourished cancer patients. JPEN J Parenter Enteral Nutr 13:501–504",
      "volume": "13",
      "year": "1989"
    },
    {
      "DOI": "10.1073/pnas.0334211100",
      "author": "D Bagga",
      "doi-asserted-by": "crossref",
      "first-page": "1751",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "9365_CR39",
      "unstructured": "Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST (2003) Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 100:1751–1756",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jn/137.1.200S",
      "author": "RS Chapkin",
      "doi-asserted-by": "crossref",
      "first-page": "200S",
      "journal-title": "J Nutr",
      "key": "9365_CR40",
      "unstructured": "Chapkin RS, Davidson LA, Ly L, Weeks BR, Lupton JR, McMurray DN (2007) Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J Nutr 137:200S–204S",
      "volume": "137",
      "year": "2007"
    },
    {
      "author": "W Becker",
      "first-page": "76",
      "journal-title": "Ugeskr Laeger",
      "key": "9365_CR41",
      "unstructured": "Becker W, Alexander J, Andersen S, Aro A, Fogelholm M, Lyhne N, Meltzer HM, Pedersen AN, Pedersen JI, Thorsdottir I (2006) Nordic nutrition recommendations. Ugeskr Laeger 168:76–77",
      "volume": "168",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s00394-008-0772-1",
      "author": "K Almendingen",
      "doi-asserted-by": "crossref",
      "first-page": "129",
      "issue": "3",
      "journal-title": "Eur J Nutr",
      "key": "9365_CR42",
      "unstructured": "Almendingen K, Fausa O, Høstmark AT, Bratlie J, Mørkerid L, Aabakken L, Vatn MH (2009) Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway. Eur J Nutr 48(3):129–136",
      "volume": "48",
      "year": "2009"
    },
    {
      "DOI": "10.1017/S000711450765795X",
      "author": "R Colomer",
      "doi-asserted-by": "crossref",
      "first-page": "823",
      "journal-title": "Br J Nutr",
      "key": "9365_CR43",
      "unstructured": "Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, Garcia-Peris P, Garcia-de-Lorenzo A, Zarazaga A, Quecedo L, de LJ, Usan L, Casimiro C (2007) N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97:823–831",
      "volume": "97",
      "year": "2007"
    }
  ],
  "reference-count": 43,
  "references-count": 43,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-010-9365-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP"
  ],
  "type": "journal-article",
  "volume": "9"
}